Dr. Erin Blake is a gynecological oncologist at c-Care in northeast Fresno. She explains that it's often hard to detect ...

Stage 2 ovarian cancer means the cancer is present in one or both ovaries and has spread to other pelvic tissues, such as the ...

Shannon Miller, a seven-time Olympic medalist, was diagnosed with ovarian cancer at 33 after missing three warning signs ...

Ovarian cancer. It's often called the silent killer because its symptoms can be so easy to overlook. It's one of the top leading causes of cancer deaths among women. Yet awareness, early detection, ...

A label expansion for Keytruda in platinum-resistant ovarian cancer would further entrench MSD’s dominance in the PD-1 space.

Merck’s efforts to make headway in a cancer type that was an elusive target for its superstar oncology med Keytruda prove to ...

Without an easy way to screen and with nondescript symptoms, ovarian cancer is often caught in late stages, requiring massive ...

International outcomes in breast, cervical, and ovarian cancers highlight opportunities to improve health-care delivery for ...

A Lancet study finds that fewer than one in five women in poorer countries are diagnosed early with breast or cervical cancer ...

Daiichi and Merck saw the highest ORR—57.1%—in patients who received the top dose of R-DXd. Yet the drugmakers have opted to take the middle 5.6 mg/kg dose into the phase 3 part of the trial. The ORR ...

BERLIN -- After multiple failed attempts, an immune checkpoint inhibitor has broken through and landed a significant overall ...